Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liposarcoma × Sugars × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 cyclopia sequence 6 Neoplasms 5 Polycystic Ovary Syndrome 3 Multiple Myeloma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Obesity 2 Neoplasms, Plasma Cell 2 Hematologic Diseases 2 Fatigue 2 Depression 2 Weight Loss 1 Warts 1 Vomiting 1 Vitamin D Deficiency 1 Urinary Bladder Neoplasms 1 Testicular Neoplasms 1 Small Cell Lung Carcinoma 1 Sleepiness 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Prostatic Intraepithelial Neoplasia 1 Primary Myelofibrosis 1 Precancerous Conditions 1 Peripheral Nervous System Diseases 1 Periampullary Carcinoma Nos 1 Pediatric Crohn's disease 1

Interventions

Doxorubicin 14 Radiotherapy 9 Ifosfamide 9 Trabectedin 7 pazopanib 3 Imatinib Mesylate 3 Filgrastim 3 temsirolimus 2 romidepsin 2 ribociclib 2 pegfilgrastim 2 eribulin 2 cixutumumab 2 brigimadlin 2 belinostat 2 Sunitinib 2 Radiotherapy, Conformal 2 Gemcitabine 2 Etoposide 2 Dexamethasone 2 Cyclophosphamide 2 Chemotherapy, Adjuvant 2 soblidotin 1 sitravatinib 1 siremadlin 1 selinexor 1 sargramostim 1 saracatinib 1 ridaforolimus 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606461 2023-01-23

SEAL

Karyopharm Therapeutics Inc

Phase 2/3 Completed

342 enrolled 36 charts

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡